{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T11:47:59Z","timestamp":1792237679190,"version":"4.4.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>Depressive symptoms occur in over 40% of neurosurgical patients during the perioperative period. However, no measure has been suggested to have a rapid effect on depressive surgical patients during increasingly shorter stays in the hospital. This study aimed to determine whether ketamine could improve depressive symptoms rapidly and safely during the hospital stay.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>\n                      This was a randomized, placebo-controlled, and double-blinded trial. Patients with moderate-to-severe depressive symptoms undergoing elective supratentorial brain tumor resection were randomized to intravenously receive either (1) 0.5 mg\u00b7kg\n                      <jats:sup>\u22121<\/jats:sup>\n                      ketamine for 40 minutes or (2) an identical volume of normal saline. The primary outcome was treatment response on postoperative day 3, defined as a \u226550% reduction from the baseline depressive score. The secondary outcomes included the rate of remission and safety outcomes. The Montgomery-\u00c5sberg Depression Rating Scale was applied by trained psychiatrists to evaluate depressive symptoms.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>A total of 84 neurosurgical patients were enrolled in the trial. The response rate was increased by the administration of ketamine (41.5% [17\/41] vs 16.3% [7\/43]; relative risk [RR]: 2.51, 95% confidence interval [CI], 1.18\u20135.50) relative to the administration of placebo at 3 days. Furthermore, the remission rate at discharge (29.3% [12\/41] vs 7.0% [3\/43]; RR: 4.20, 95% CI, 1.28\u201313.80) was also improved by ketamine. No psychotic symptoms or adverse events were reported to be substantially higher in the ketamine group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>The trial indicates that the intraoperative administration of ketamine could alleviate moderate-to-severe depressive symptoms in neurosurgical patients without worsening safety.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1213\/ane.0000000000005752","type":"journal-article","created":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T17:17:04Z","timestamp":1633972624000},"page":"1588-1597","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":42,"title":["Ketamine Alleviates Depressive Symptoms in Patients Undergoing Intracranial Tumor Resection: A Randomized Controlled Trial"],"prefix":"10.1213","volume":"133","author":[{"given":"Yang","family":"Zhou","sequence":"first","affiliation":[{"name":"Department of Anesthesiology, Beijing Tiantan Hospital Capital Medical University, Beijing, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanchen","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Beijing Tiantan Hospital Capital Medical University, Beijing, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guofu","family":"Zhang","sequence":"additional","affiliation":[{"name":"China & Beijing Key Laboratory of Mental Disorders, National Clinical Research Center for Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, People\u2019s Republic of China"},{"name":"Department of Psychiatry, Capital Medical University, China & Center of Depression, Beijing Institute for Brain Disorders, Beijing, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anxin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Statistics, China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew T. V.","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Anesthesia and Intensive Care, the Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong Special Administrative Region, People\u2019s Republic of China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuming","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Beijing Tiantan Hospital Capital Medical University, Beijing, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Wang","sequence":"additional","affiliation":[{"name":"China & Beijing Key Laboratory of Mental Disorders, National Clinical Research Center for Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, People\u2019s Republic of China"},{"name":"Department of Psychiatry, Capital Medical University, China & Center of Depression, Beijing Institute for Brain Disorders, Beijing, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruquan","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Beijing Tiantan Hospital Capital Medical University, Beijing, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,10,11]]},"reference":[{"key":"R1-20250502","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/jnci\/djq458","article-title":"Depression in cerebral glioma patients: a systematic review of observational studies.","volume":"103","author":"Rooney","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"R2-20250502","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1097\/SLA.0000000000001448","article-title":"Influence of depression on recovery after major noncardiac surgery: a prospective cohort study.","volume":"262","author":"Orri","year":"2015","journal-title":"Ann Surg"},{"key":"R3-20250502","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.clineuro.2011.05.006","article-title":"Depression in relation to anxiety, obsessionality and phobia among neurosurgical patients with a primary brain tumor: a 1-year follow-up study.","volume":"113","author":"Mainio","year":"2011","journal-title":"Clin Neurol Neurosurg"},{"key":"R4-20250502","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1215\/15228517-2007-057","article-title":"Evaluation and characterization of generalized anxiety and depression in patients with primary brain tumors.","volume":"10","author":"Arnold","year":"2008","journal-title":"Neuro Oncol"},{"key":"R5-20250502","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1023\/A:1015728825642","article-title":"Quality of life in brain tumor patients: the relative contributions of depression, fatigue, emotional distress, and existential issues.","volume":"57","author":"Pelletier","year":"2002","journal-title":"J Neurooncol"},{"key":"R6-20250502","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1253\/circj.CJ-16-0829","article-title":"Depression and outcomes in Japanese outpatients with cardiovascular disease - a prospective observational study.","volume":"80","author":"Suzuki","year":"2016","journal-title":"Circ J"},{"key":"R7-20250502","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1176\/appi.ajp.2016.16010037","article-title":"A double-blind, randomized, placebo-controlled, dose-frequency study of intravenous ketamine in patients with treatment-resistant depression.","volume":"173","author":"Singh","year":"2016","journal-title":"Am J Psychiatry"},{"key":"R8-20250502","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1017\/S0033291716000064","article-title":"Single-dose infusion ketamine and non-ketamine N-methyl-d-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories.","volume":"46","author":"Kishimoto","year":"2016","journal-title":"Psychol Med"},{"key":"R9-20250502","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1001\/jamapsychiatry.2017.0080","article-title":"A consensus statement on the use of ketamine in the treatment of mood disorders.","volume":"74","author":"Sanacora","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"R10-20250502","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/00000539-200207000-00020","article-title":"Small-dose ketamine improves the postoperative state of depressed patients.","volume":"95","author":"Kudoh","year":"2002","journal-title":"Anesth Analg"},{"key":"R11-20250502","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s00540-015-2096-7","article-title":"Effect of intraoperative application of ketamine on postoperative depressed mood in patients undergoing elective orthopedic surgery.","volume":"30","author":"Jiang","year":"2016","journal-title":"J Anesth"},{"key":"R12-20250502","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.bja.2018.03.030","article-title":"Intraoperative ketamine for prevention of depressive symptoms after major surgery in older adults: an international, multicentre, double-blind, randomised clinical trial.","volume":"121","author":"Mashour","year":"2018","journal-title":"Br J Anaesth"},{"key":"R13-20250502","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S2215-0366(17)30272-9","article-title":"Side-effects associated with ketamine use in depression: a systematic review.","volume":"5","author":"Short","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"R14-20250502","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00213-007-0706-2","article-title":"Psychiatric safety of ketamine in psychopharmacology research.","volume":"192","author":"Perry","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"key":"R15-20250502","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1186\/s13063-018-2831-0","article-title":"Effect of low-dose ketamine on PerioperAtive depreSsive Symptoms in patients undergoing Intracranial tumOr resectioN (PASSION): study protocol for a randomized controlled trial.","volume":"19","author":"Zhou","year":"2018","journal-title":"Trials"},{"key":"R16-20250502","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(00)04337-3","article-title":"The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials.","volume":"357","author":"Moher","year":"2001","journal-title":"Lancet"},{"key":"R17-20250502","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1001\/jama.282.18.1737","article-title":"Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire.","volume":"282","author":"Spitzer","year":"1999","journal-title":"JAMA"},{"key":"R18-20250502","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change.","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br J Psychiatry"},{"key":"R19-20250502","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1055\/s-2006-946702","article-title":"Effective dose of escitalopram in moderate versus severe DSM-IV major depression.","volume":"39","author":"Bech","year":"2006","journal-title":"Pharmacopsychiatry"},{"key":"R20-20250502","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1017\/S0033291715002159","article-title":"Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study.","volume":"46","author":"Hu","year":"2016","journal-title":"Psychol Med"},{"key":"R21-20250502","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jpsychires.2004.03.007","article-title":"Derivation of a definition of remission on the Montgomery-Asberg depression rating scale corresponding to the definition of remission on the Hamilton rating scale for depression.","volume":"38","author":"Zimmerman","year":"2004","journal-title":"J Psychiatr Res"},{"key":"R22-20250502","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1097\/00003246-200107000-00012","article-title":"Evaluation of delirium in critically ill patients: validation of the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU).","volume":"29","author":"Ely","year":"2001","journal-title":"Crit Care Med"},{"key":"R23-20250502","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1016\/S0140-6736(06)68700-X","article-title":"Persistent postsurgical pain: risk factors and prevention.","volume":"367","author":"Kehlet","year":"2006","journal-title":"Lancet"},{"key":"R24-20250502","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity.","volume":"133","author":"Young","year":"1978","journal-title":"Br J Psychiatry"},{"key":"R25-20250502","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.psychres.2009.03.003","article-title":"Clinical predictors of response to olanzapine or risperidone during acute episode of schizophrenia.","volume":"179","author":"Brousse","year":"2010","journal-title":"Psychiatry Res"},{"key":"R26-20250502","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1023\/A:1024465317902","article-title":"Measurement of dissociative states with the Clinician-Administered Dissociative States Scale (CADSS).","volume":"11","author":"Bremner","year":"1998","journal-title":"J Trauma Stress"},{"key":"R27-20250502","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"R28-20250502","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.biopsych.2012.06.022","article-title":"Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression.","volume":"74","author":"Murrough","year":"2013","journal-title":"Biol Psychiatry"},{"key":"R29-20250502","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1586\/14737175.7.4.343","article-title":"Psychiatric manifestations of brain tumors: diagnostic implications.","volume":"7","author":"Madhusoodanan","year":"2007","journal-title":"Expert Rev Neurother"},{"key":"R30-20250502","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1016\/j.apmr.2017.05.024","article-title":"Pain intensity, interference, and medication use after spinal cord injury: association with risk of mortality after controlling for socioeconomic and other health factors.","volume":"98","author":"Krause","year":"2017","journal-title":"Arch Phys Med Rehabil"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000005752","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:34:23Z","timestamp":1786113263000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000005752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,11]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000005752","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10,11]]}}}